Bonifacio, Rosalyn L.

HRN: 10-58-22  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/15/2022
CEFUROXIME 500MG (TAB)
09/15/2022
09/21/2022
ORAL
500
Bid
Msaf
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Reproductive TractProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: